EUVIMEDEUVIMED entdecken
Crossref

Retraction Note: Telomerase gene therapy: a remission toward cancer

Sameer Quazi

Medical Oncology · 26.06.2026 · 43 (8)

DOI: 10.1007/s12032-026-03327-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 26.06.2026. Verfasst von Sameer Quazi. Beteiligte Einrichtung: GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.
  • Department of Biomedical Sciences, School of Life Science, Anglia Ruskin University, Cambridge, UK. Colonel.quazi@gmail.com.

Zitieren

APA

Quazi, S. (2026). Retraction Note: Telomerase gene therapy: a remission toward cancer. Medical Oncology, 43(8). https://doi.org/10.1007/s12032-026-03327-1

Vancouver

Quazi S. Retraction Note: Telomerase gene therapy: a remission toward cancer. Medical Oncology. 2026;43(8). doi:10.1007/s12032-026-03327-1

BibTeX
@article{Quazi2026,
  author = {Quazi, Sameer},
  title = {Retraction Note: Telomerase gene therapy: a remission toward cancer},
  journal = {Medical Oncology},
  year = {2026},
  volume = {43},
  number = {8},
  doi = {10.1007/s12032-026-03327-1}
}
Kostenlos starten →